Benjamin Graham fit · Inversión deep-value defensiva
Is Theravance Biopharma, Inc. (TBPH) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
22/100
FNo encaja
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a TBPH
P/E ≤ 15
clave—
P/B ≤ 1.5
clave0.0x
Current ratio ≥ 2
9.5x
Debt / Equity ≤ 1
0.0x
Cómo se valora TBPH en otras estrategias
Datos financieros en vivo
Cap. mercado
$843.92M
PER (TTM)
7.4x
ROIC (TTM)
-1.32%
Margen bruto
-
Otros análisis Benjamin Graham
Preguntas frecuentes
What is TBPH's Benjamin Graham fit score?
TBPH scores 22/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own TBPH?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends TBPH.
How often is this score updated?
TBPH's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende TBPH personalmente.